MedPath

Sleep Laboratory Study of MK0928 in Adult Patients With Primary Insomnia (0928-041)(TERMINATED)

Phase 2
Terminated
Conditions
Primary Insomnia
Registration Number
NCT00266357
Lead Sponsor
H. Lundbeck A/S
Brief Summary

A study to evaluate the efficacy, safety and tolerability of MK-0928 in Primary Insomnia.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
50
Inclusion Criteria
  • Patients with a diagnosis of primary insomnia
Exclusion Criteria
  • Patients with an active psychiatric disorder other than primary insomnia

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
Mean of total sleep time over 2 nights.
Secondary Outcome Measures
NameTimeMethod
Mean of other PSG sleep parameters over 2 nights, mean of subjective sleep parameters, and exploratory residual effect.
© Copyright 2025. All Rights Reserved by MedPath